|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/352 | |
| A61P 1/16 | |||
| A61P 13/12 | |||
| A61P 17/00 | |||
| A61P 11/00 | |||
| A61P 21/00 | |||
| A61P 29/00 |
| (11) | Number of the document | 2717692 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12796691.9 |
| Date of filing the European patent application | 2012-06-01 | |
| (97) | Date of publication of the European application | 2014-04-16 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/040380 |
| Date | 2012-06-01 |
| (87) | Number | WO 2012/170290 |
| Date | 2012-12-13 |
| (30) | Number | Date | Country code |
| 201161493435 P | 2011-06-04 | US | |
| 201213485044 | 2012-05-31 | US |
| (72) |
ZURIER, Robert, B., US
SELVI, Enrico, IT
|
| (73) |
Corbus Pharmaceuticals, Inc.,
100 River Ridge Drive, Norwood, MA 02062,
US
|
| (54) | TETRAHYDROCANNABINOL-11-OIC ACIDS FOR USE IN TREATING FIBROTIC DISEASES |
| TETRAHYDROCANNABINOL-11-OIC ACIDS FOR USE IN TREATING FIBROTIC DISEASES |